Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06401265

Enrollment

8000

Registered

2024-05-06

Start date

2018-01-01

Completion date

2022-09-05

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cancer

Brief summary

Among urothelial cancers, upper urinary tract urothelial cancers, including renal pelvis and ureteral cancers have a higher incidence rate in Taiwan than Western countries. In particular, the proportion of female patients is similar to that of males. This situation is significantly different from that in foreign countries. The cause is currently uncertain.In the past, the arsenic contamination of groundwater made blackfoot disease become common and malignant in areas. Now, the number of kidney dialysis patients in Taiwan is increasing; and according to statistics, there is a significantly higher incidence of urothelial cancer among kidney dialysis patients. This may be caused by the use of traditional Chinese medicine or other unknown reasons.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Case study of upper urinary tract urothelial cancer surgery

Exclusion criteria

* Cases of surgery for non-upper urinary tract urothelial cancer

Design outcomes

Primary

Measure	Time frame
It is a retrospective and questionnaire-based study.	Patients with urothelial carcinoma of the upper urinary tract from January 2008 to December 2019.

Countries

Taiwan

Outcome results